Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Linsitinib | 1 | uM | 8 | 156.25 | 36.27 | 96.00 | 111.50 | 0.8610 | 0.8235 |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 105.00 | 111.50 | 0.9417 | 0.9272 | |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 99.00 | 111.50 | 0.8879 | 0.8585 | |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 104.00 | 111.50 | 0.9327 | 0.9159 | |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 103.00 | 111.50 | 0.9238 | 0.9045 | |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 8 | 156.25 | 36.27 | 33.00 | 111.50 | 0.2960 | -0.0567 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 8 | 156.25 | 36.27 | 176.00 | 111.50 | 1.5785 | 1.6509 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 8 | 156.25 | 36.27 | 127.00 | 111.50 | 1.1390 | 1.1673 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 8 | 156.25 | 36.27 | 158.00 | 111.50 | 1.4170 | 1.4801 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 8 | 156.25 | 36.27 | 167.00 | 111.50 | 1.4978 | 1.5664 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 8 | 156.25 | 36.27 | 123.00 | 111.50 | 1.1031 | 1.1249 |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 118.00 | 111.50 | 1.0583 | 1.0712 | |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 8 | 156.25 | 36.27 | 101.00 | 111.50 | 0.9058 | 0.8816 |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 156.00 | 111.50 | 1.3991 | 1.4607 | |
| SK-BR-3 | Linsitinib | 0.01 | uM | 8 | 156.25 | 36.27 | 133.00 | 111.50 | 1.1928 | 1.2299 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 8 | 156.25 | 36.27 | 73.00 | 111.50 | 0.6547 | 0.5399 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 8 | 156.25 | 36.27 | 130.00 | 111.50 | 1.1659 | 1.1988 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 8 | 156.25 | 36.27 | 66.00 | 111.50 | 0.5919 | 0.4470 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 8 | 156.25 | 36.27 | 59.00 | 111.50 | 0.5292 | 0.3503 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 8 | 156.25 | 36.27 | 116.00 | 111.50 | 1.0404 | 1.0494 |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 81.00 | 111.50 | 0.7265 | 0.6420 | |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 8 | 156.25 | 36.27 | 255.00 | 111.50 | 2.2870 | 2.3325 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 8 | 156.25 | 36.27 | 143.00 | 111.50 | 1.2825 | 1.3320 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 8 | 156.25 | 36.27 | 119.00 | 111.50 | 1.0673 | 1.0820 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 8 | 156.25 | 36.27 | 54.00 | 111.50 | 0.4843 | 0.2784 |